Abstract
Background
The aim of this work is to determine the systemic diseases and malignancy associated with Vogt–Koyanagi–Harada (VKH) disease compared to sympathetic ophthalmia (SO).
Methods
We conducted a retrospective comparative observational clinical study where the medical records of patients with the diagnosis of VKH and SO from 1999–2009 were reviewed. The study was carried out at the King Khaled Eye Specialist Hospital and The Eye Center in Riyadh, Saudi Arabia. Investigators recorded the age, gender, history of trauma, associated systemic disorders, and ocular and systemic manifestations. Patients were examined by an ophthalmologist as well as an internist.
Results
A total of 316 patients were included: 256 patients had VKH and 60 patients had SO. The age range in the VKH group was 3–62 years with a mean age of 29 ± 13 years. The age range in the SO group was 4–90 years with a mean age of 36 ± 20 years. The mean follow-up period of patients with VKH was 58 ± 50 months and patients with SO was 61 ± 54 months. Out of 256 patients with VKH, there were 41 (16%) with systemic disorders. Comparatively, out of 60 patients with SO, no associated systemic autoimmune disorders or tumors were encountered. The difference between the VKH and SO groups was statistically significant (p = 0.003).
Conclusions
VKH and SO are autoimmune disorders targeting melanin-bearing cells. Both diseases are characterized by immunologic dysregulation. We found a statistically significant association of systemic disorders and malignancy with VKH compared to SO. This finding may suggest that the two disorders may have different etiology with similar ocular and systemic manifestations.
Similar content being viewed by others
References
Islam SM, Tabbara KF (2002) Causes of uveitis at The Eye Center in Saudi Arabia: a retrospective review. Ophthalmic Epidemiol 9:239–249
Hamade IH, ElKum N, Tabbara KF (2009) Causes of uveitis at a referral center in Saudi Arabia. Ocul Immunol Inflamm 17:11–16
Al Hemidan AI, Tabbara KF, Althomali T (2006) Vogt–Koyanagi–Harada associated with diabetes mellitus and celiac disease in a 3-year-old girl. Eur J Ophthalmol 16:173–177
Pahk PJ, Todd DJ, Blaha GR, Soukiasian SH, Landmann DS, Craven DE, Tronic BS, Zabar Y, Marx JL (2008) Intravascular lymphoma masquerading as Vogt–Koyanagi–Harada syndrome. Ocul Immunol Inflamm 16:123–126
Kumar A, Chhabra MS, Prakash G, Kulkarni AD (2005) Vogt–Koyanagi–Harada syndrome with intracranial meningioma: an as yet unreported association. Can J Ophthalmol 40:725–728
Hashida N, Kanayama S, Kawasaki A, Ogawa K (2005) A case of Vogt–Koyanagi–Harada disease associated with malignant lymphoma. Jpn J Ophthalmol 49:253–256
Hon C, Ho SL, Ma ES, Trendell-Smith NJ, Au WY (2005) High-grade lymphoma after azathioprine treatment for Vogt–Koyanagi–Harada syndrome. Leuk Lymphoma 46:289–292
Norose K, Yano A (1996) Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt–Koyanagi–Harada disease. Br J Ophthalmol 80:1002–1008
Matsuzaki Y, Hashimoto S, Fujita T, Suzuki T, Sakurai T, Matsushima K, Kawakami Y (2005) Systematic identification of human melanoma antigens using serial analysis of gene expression (SAGE). J Immunother 28:10–19
Cipriani D, Landonio G, Canepari C (1989) A case of Vogt–Koyanagi–Harada syndrome in a patient affected by Hodgkin's disease. J Neurol 236:303–304
Pezzi PP, Paroli MP, Priori R, Da Dalt S, Corradi R (2004) Vogt–Koyanagi–Harada syndrome and keratoconjunctivitis sicca. Am J Ophthalmol 137:769–770
Read RW, Rao NA, Cunningham ET (2000) Vogt–Koyanagi–Harada disease. Curr Opin Ophthalmol 11:437–442
Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, Pivetti-Pezzi P, Tessler HH, Usui M (2001) Revised diagnostic criteria for Vogt–Koyanagi–Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 131:647–652
McClellan KA, MacDonald M, Hersey P, Billson FA (1989) Vogt–Koyanagi–Harada syndrome – isolation of cloned T cells with specificity for melanocytes and melanoma cells. Aust NZJ Ophthalmol 17:347–352
Sakamoto T, Murata T, Inomata H (1991) Class II major histocompatibility complex on melanocytes of Vogt–Koyanagi–Harada disease. Arch Ophthalmol 109:1270–1274
Damico FM, Cunha-Neto E, Goldberg AC, Iwai LK, Marin ML, Hammer J, Kalil J, Yamamoto JH (2005) T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt–Koyanagi–Harada uveitis. Invest Ophthalmol Vis Sci 46:2465–2471
Goldberg AC, Yamamoto JH, Chiarella JM, Marin ML, Sibinelli M, Neufeld R, Hirata CE, Olivalves E, Kalil J (1998) HLA-DRB1*0405 is the predominant allele in Brazilian patients with Vogt–Koyanagi–Harada disease. Hum Immunol 59:183–188
Chuah SY, Lyne AJ, Dronfield MW (1991) Vogt–Koyanagi–Harada syndrome, a rare association of Hodgkin’s disease. Postgrad Med J 67:476–478
Walker J, Ober RR, Khan A, Yuen D, Rao NA (1993–1994) Intraocular lymphoma developing in a patient with Vogt-Koyanagi- Harada syndrome. Int Ophthalmol 17:331–336
Aisenbrey S, Lüke C, Ayertey HD, Grisanti S, Perniok A, Brunner (2003) Vogt-Koyanagi–Harada syndrome associated with cutaneous malignant melanoma: an 11-year follow-up. Graefe’s Arch Clin Exp Ophthalmol 241:996–999
Kempen JH, Daniel E, Dunn JP, Foster CS, Gangaputra S, Hanish A, Helzlsouer KJ, Jabs DA, Kaçmaz RO, Levy-Clarke GA, Liesegang TL, Newcomb CW, Nussenblatt RB, Pujari SS, Rosenbaum JT, Suhler EB, Thorne JE (2009) Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study. BMJ Jul 3;339:b2480. doi:10.1136/bmj.b2480. PMID: 19578087
Acknowledgments
This study was supported in part by funding from The Eye Center and The Eye Foundation for Research in Ophthalmology and the King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.
Financial disclosures
The authors have no proprietary or commercial interests in any of the materials discussed in this study.
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(DOC 28 kb)
Rights and permissions
About this article
Cite this article
Al-Halafi, A., Dhibi, H.A., Hamade, I.H. et al. The association of systemic disorders with Vogt–Koyanagi–Harada and sympathetic ophthalmia. Graefes Arch Clin Exp Ophthalmol 249, 1229–1233 (2011). https://doi.org/10.1007/s00417-011-1727-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-011-1727-4